Similar Papers

Paper Title
Journal
Date
Author
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
Gabriel N Hortobagyi ... Robert D Knight
New England Journal of Medicine | VOL. 335
Gabriel N Hortobagyi, et. al.Gabriel N Hortobagyi ... Robert D Knight
12 Dec 1996
Efficacy of pamidronate on skeletal complications from breast cancer metastases. A prospective randomized double-blind placebo-controlled trial
R Hultborn ... U.-B Wallgren
Bone | VOL. 17
R Hultborn, et. al.R Hultborn ... U.-B Wallgren
01 Dec 1995
350 Efficacy of pamidronate on skeletal complications from breast cancer metastases. A prospective randomized double blind placebo controlled trial
R Hultborn ... U-B Wallgnn
European Journal of Cancer | VOL. 31
R Hultborn, et. al.R Hultborn ... U-B Wallgnn
01 Nov 1995
ABC 1 (1st International consensus guidelines for advanced breast cancer): A positive step
Kathleen I Pritchard ... Berta Sousa
The Breast | VOL. 21
Kathleen I Pritchard, et. al.Kathleen I Pritchard ... Berta Sousa
01 Jun 2012
View more papers

More From: The Breast

Paper Title
Journal
Date
Author
Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i): Mechanisms of resistance and where to find them
L Foffano ... F Puglisi
The Breast | VOL. 79
L Foffano, et. al.L Foffano ... F Puglisi
01 Feb 2025
Safety Profile of Sacituzumab Govitecan in Patients with Breast Cancer: A Systematic Review and Meta-Analysis
Maria Inez Dacoregio ... Ricardo Lima Barros Costa
The Breast | VOL. 79
Maria Inez Dacoregio, et. al.Maria Inez Dacoregio ... Ricardo Lima Barros Costa
01 Feb 2025
Reply to the letter: What can paintings teach us?
Serena Di Cosimo ... Raffaella Bianucci
The Breast | VOL. -
Serena Di Cosimo, et. al.Serena Di Cosimo ... Raffaella Bianucci
01 Jan 2025
Multimodal data integration in early-stage breast cancer
Arnau Llinas-Bertran ... Jose A Seoane
The Breast | VOL. -
Arnau Llinas-Bertran, et. al.Arnau Llinas-Bertran ... Jose A Seoane
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.